MALVX | VIVAX | MALVX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 25 years | 32 years | - |
Gain YTD | 2.943 | 3.194 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 3000 | 66,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 650M | 184B | 0% |
Annual Yield % from dividends | 1.49 | 2.25 | 66% |
Returns for 1 year | 6.65 | 18.19 | 37% |
Returns for 3 years | 5.32 | 18.46 | 29% |
Returns for 5 years | 15.10 | 44.18 | 34% |
Returns for 10 years | 61.32 | 111.10 | 55% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WAYFX | 17.35 | 0.19 | +1.11% |
Waycross Focused Core Equity Fund | |||
BGEFX | 12.97 | 0.03 | +0.27% |
Baillie Gifford International Growth 4 | |||
SEVSX | 20.89 | 0.04 | +0.19% |
NAA SMid Cap Value C | |||
QQMNX | 20.41 | -0.07 | -0.34% |
Federated Hermes MDT Market Neutral IS | |||
VGHCX | 182.55 | -1.63 | -0.88% |
Vanguard Health Care Inv |